RBBP4 regulates the expression of the Mre11-Rad50-NBS1 (MRN) complex and promotes DNA double-strand break repair to mediate glioblastoma chemoradiotherapy resistance
Authors:
- 2 February 2023
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 557, 216078
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair GeneRad51Clinical Cancer Research, 2012
- Chromodomain Helicase DNA-binding Protein 4 (CHD4) Regulates Homologous Recombination DNA Repair, and Its Deficiency Sensitizes Cells to Poly(ADP-ribose) Polymerase (PARP) Inhibitor TreatmentJournal of Biological Chemistry, 2012
- Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastomaFrontiers in Oncology, 2012
- Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cellsNeuro-Oncology, 2011
- L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1The EMBO Journal, 2011
- O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patientsNeuro-Oncology, 2009
- Mechanisms of Chemoresistance to Alkylating Agents in Malignant GliomaClinical Cancer Research, 2008
- Chaperone-mediated assembly of centromeric chromatinin vitroProceedings of the National Academy of Sciences, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste proteinGenes & Development, 2002